ASMS: Thermo Fisher Scientific Annual users meetings
Annual users meetings | Sunday, June 2, 2024 | Hilton Anaheim
7 - 8 a.m. PDT: Breakfast & registration
8 - 9:40 a.m. PDT: The future of translational omics panel (Hilton Anaheim - California Ballroom)
Hear from leaders in the field about how discovering & validating insights at unprecedented scale has never been easier than before, with new technology revealing biological insights into disease mechanisms and clinical research outcomes. Learn about the latest advances in mass spectrometry for proteomics, metabolomics, and translational research.
Speakers:
- Iain Mylchreest, Ph.D., Vice President, Research and Development AIG, Thermo Fisher Scientific
- Michael MacCoss, Ph.D., Professor of Genome Sciences, University of Washington
- Jennifer Van Eyk, Ph.D., Director of Advanced Clinical Biosystems Institute, Cedars-Sinai Medical Center
- Jeffrey Whiteaker, Ph.D., Director of Proteomics, Fred Hutchinson Cancer Research Center
- Bruce Wilcox, Ph.D., Chief Technology Officer at PrognomiQ
- Crystal Pace, Ph.D., Senior Research Scientist, Metabolon
- Gary Patti, Ph.D., Professor of Chemistry, Washington University in St. Louis
- Matthias Mann, Ph.D., Professor of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry
9:40 a.m. - 12 p.m. PDT: Proteomics breakout: Peptides, Proteins, PTMs, and Proteoforms (Hilton Anaheim - California Ballroom C & D)
Hear from experts on diverse proteomic applications ranging from single cell proteomics, PTMs, immunopeptidomics using new approaches for label free quantitation and multiplexing approaches.
Speakers:
- Steven Gygi, Ph.D., Professor of Cell Biology, Harvard Medical School
- Karl Mechtler, Ph.D., Head Proteomics Tech Hub, Research Institute of Molecular Pathology
- Lisa Jones, Ph.D., Professor of Chemistry and Biochemistry, University of California, San Diego
- Pierre Thibault, Ph.D., Professor of Chemistry, Université de Montréal
- Brian Searle, Ph.D., Assistant Professor of Chemistry and Biochemistry, Ohio State University
9:40 a.m. - 12 p.m. PDT: Metabolomics breakout: Metabolites, Lipids, and MultiOmics methods (Hilton Anaheim - Pacific Ballroom A & B)
From metabolomics to lipidomics hear about the most recent advances for comprehensive small molecule characterization and quantitation using SQUAD, untargeted discovery, targeted validation and imaging methods.
Speakers:
- Crystal Pace, Ph.D., Senior Research Scientist, Metabolon
- Philip Lorenzi, Ph.D., Director of Metabolomics & Proteomics Cores, MD Anderson Cancer Center
- Uri Keshet, Ph.D., Technical Director, Metabolomics Core, University of California, Davis
- Bernhard Spengler, Ph.D., Professor of Analytical Chemistry, Justus Liebig University Giessen
- Facundo Fernandez, Ph.D., Professor of Chemistry and Biochemistry, Georgia Institute of Technology
9:40 a.m. - 12 p.m. PDT: BioPharma/Structural Biology breakout: Empowering discovery and development for large and small molecules (Hilton Anaheim - California Ballroom A)
Hear from end users about applying the state-of-the-art LCMS technologies to accelerate pharmaceutical and biopharmaceutical discovery and development, covering diverse applications of chemoproteomics, comprehensive antibody-drug conjugate characterization, disulfide bond mapping, and cell culture media analysis.
Speakers:
- Aman Makaju, Ph.D., Scientist at Amgen
- Luca Fornelli, Ph.D., Assistant Professor of Biology, University of Oklahoma
- Ben Niu, Ph.D., Principal Scientist at Bristol Myers Squibb
- Richard Scheltema, Ph.D., Professor of Structural Proteomics, University of Liverpool
- Elsa Gorre, Ph.D., Senior Scientist, Johnson & Johnson
9:40 a.m. - 12 p.m. PDT: Clinical & EFS breakout: Innovations in clinical and translational research (Hilton Anaheim - California Ballroom B)
Hear from experts on the latest innovations for diagnostic research studying diseases from Alzheimer’s, Oncology, and Diabetes by measuring protein, lipid, metabolite biomarkers and PFAS using standardized LC-MS workflows for clinical research and environmental safety.
Speakers:
- Joel Braunstein, M.D., Chief Executive Officer, C2N Diagnostics
- Steve Sweet, Ph.D., Director, Diagnostic Proteomics at AstraZeneca
- Jun Qu, Ph.D., Professor of Pharmaceutical Sciences, University at Buffalo
- Sangtae Kim, Ph.D., Chief Technology Officer at Bertis Bioscience
- Lee Ferguson, Ph.D., Associate Professor of Ecotoxicology and Environmental Health at Duke University
